Quantcast
Last updated on April 17, 2014 at 21:23 EDT

Latest pharmaceutical industry Stories

2014-03-31 23:32:30

Combined companies provide unrivalled capabilities for adaptive and medical device trials worldwide. Reston, Virginia (PRWEB) March 31, 2014 Aptiv Solutions, a global biopharmaceutical and medical device development services company leading the design and implementation of innovative approaches that improve data quality, efficiency, and productivity of product development today announced that it has agreed, subject to certain closing conditions, to be acquired by ICON plc, (NASDAQ: ICLR),...

2014-03-31 23:27:15

Information on the risks, side effects, and dangers of prescription medication, as well as tips on medicine safety as provided by the attorneys at http://www.JRLawFirm.com/. (PRWEB) March 31, 2014 Medication Safety Week begins the 1st of April, presenting the public with an opportunity to brush up on their knowledge of medication dangers. It’s important to educate oneself on the risks, side effects, and other dangers of prescription medication. A 1999 report by the Institute of...

2014-03-31 23:23:07

GetReal project seeks practical solutions for integrating real-world data to better inform the drug development process. Washington (PRWEB) March 31, 2014 GetReal, a collaborative project recently launched by the European Union’s Innovative Medicines Initiative (IMI), will be highlighted at the DIA 2014 50th Annual Meeting taking place June 15 to 19 at the San Diego Convention Center. The forum discussion—How Can Studies That Inform Relative Effectiveness Best Be Incorporated Into...

2014-03-31 20:22:46

INDIANAPOLIS, March 31, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that the U.S. District Court for the Southern District of Indiana has ruled in the company's favor regarding the vitamin dosage regimen patent for Alimta(®) (pemetrexed for injection). In the case of Eli Lilly and Company v. Teva Parenteral Medicines Inc., et al., the court ruled the vitamin dosage regimen patent is valid and enforceable. The patent provides intellectual property protection...

2014-03-31 20:22:33

DUBLIN, April 1, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/5q5tcr/global_orphan) has announced the addition of the "Concise Analysis of the International Orphan Drug Market Outlook 2018" [http://www.researchandmarkets.com/research/5q5tcr/global_orphan ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The global pharmaceutical industry has been experiencing a slow growth in recent...

2014-03-31 16:27:39

LA JOLLA, Calif., March 31, 2014 /PRNewswire/ -- Auspex Pharmaceuticals, Inc. (Nasdaq: ASPX), a late clinical stage biopharmaceutical company focused on developing and commercializing novel medicines for the treatment of orphan diseases, today announced that the Company was added to the Russell 2000® Index (as well as the larger Russell 3000® Index) at the close of market on March 31, 2014 as part of the quarterly Initial Public Offering (IPO) update to the Russell indexes. The...

2014-03-31 16:27:19

CRANBURY, N.J., March 31, 2014 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential, announced that it has granted an extension until April 30, 2014 to an existing option agreement with a potential commercial partner for an exclusive license to bremelanotide for female sexual dysfunction indications in...

2014-03-31 16:26:29

EMERYVILLE, Calif. and OSAKA, Japan, March 31, 2014 /PRNewswire/ -- Trianni, Inc. ("Trianni") and Takeda Pharmaceutical Company Limited ("Takeda") jointly announced today that they have entered into a license agreement for Takeda's use of the Trianni Mouse, a monoclonal antibody discovery platform. Distinguished by a novel chimeric gene segment design, the Trianni platform provides Takeda with easy access to a complete human antibody repertoire that has been optimized for the...

2014-03-31 12:29:39

LONDON, March 31, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: United States Pharmaceuticals and Healthcare Report Q1 2014 Includes 3 FREE quarterly updates BMI View:Despite the botched rollout of the Affordable Care Act, we expect reform of the US healthcaresystem to continue over the coming years, mainly due to the need to control growth in spending on medicalservices. Implementation will not be smooth due to the law's numerous opponents. We...

2014-03-31 08:28:28

More than half of biopharmaceutical companies surveyed use a Strategic Partnership model BOSTON, March 31, 2014 /PRNewswire/ -- PAREXEL International (NASDAQ: PRXL), a leading global biopharmaceutical services organization, today released Strategic Partnerships 2014: Driving Biopharmaceutical Outsourcing Effectiveness, at the 23rd Annual Partnerships in Clinical Trials Conference in Las Vegas, NV. It provides compelling insights that highlight the value of these multi-year, highly integrated...